$ADAP #Stocks #StockMarket #AdaptimmuneTherapeuticsPlc reported Q4 EPS on https://t.co/savSNTKlN1: from preceding quarter from $-0.06 per share, Sales doubled by 207.173 % from $0 millions. https://t.co/YaoJ5A1Lr5